Royalty Pharma plc logo RPRX - Royalty Pharma plc

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 11
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $56.67 DETAILS
HIGH: $63.00
LOW: $50.00
MEDIAN: $57.00
CONSENSUS: $56.67
UPSIDE: 0.39%

About Royalty Pharma plc (https://www.royaltypharma.com)

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Key Executives

NAME TITLE DOB SALARY
Pablo Legorreta Founder, Chairman of the Board & Chief Executive Officer 1963 $44,019,342 USD
Arthur Richard McGivern Executive Vice President of Investments & Chief Scientific Officer 1975 $3,395,000 USD
James Folmar Reddoch Executive Vice President of Investments & Chief Scientific Officer 1970 $3,395,000 USD
Christopher Hite Chairman of Partnering & Investments 1967 $1,323,000 USD
Marshall Urist Executive Vice President of Research & Investments 1976 $1,323,000 USD
Terrance Coyne Executive Vice President & Chief Financial Officer $1,323,000 USD
Ashwin Pai Executive Vice President of Investments & Partnering
Eric Cornelius Schneider Senior Vice President & Chief Technology Officer
George Grofik Senior Vice President and Head of Investor Relations & Communications
Kenneth Siming Sun Senior VP & Head of Asia
Lucas Glass Head of Artificial Intelligence
Molly Sawaya Executive Vice President & Head of Human Capital
Sam Landsberg Finance and Treasurer
Sandy Balkin Senior Vice President of Strategy & Analytics
Sara Klymkowsky Senior Vice President of Research & Investments
Scott Raichilson Chief Accounting Officer

Company Peers

Peer analysis pending, check back in 1-2 minutes.